{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:56Z","timestamp":1787169596520,"version":"build-2736575974"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Human brain is composed of 25% of the cholesterol &amp; any dysfunction in brain cholesterol homeostasis contributes to neurodegenerative disorders such as Parkinson, Alzheimer\u2019s, Huntington\u2019s disease, etc. A growing literature indicates that alteration in neurotransmission &amp; brain cholesterol metabolism takes place in the early stage of the disease. The current paper summarizes the role of cholesterol &amp; its homeostasis in the pathophysiology of Parkinson\u2019s disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Literature findings suggest the possible role of lipids such as oxysterols, lipoproteins, etc. in Parkinson\u2019s disease pathophysiology. Cholesterol performs a diverse role in the brain but any deviation in its levels leads to neurodegeneration. Dysregulation of lipid caused by oxidative stress &amp; inflammation leads to \u03b1-synuclein trafficking which contributes to Parkinson\u2019s disease progression. Also, \u03b1-synuclein by binding to membrane lipid forms lipid-protein complex &amp; results in its aggregation. Different targets such as Phospholipase A2, Stearoyl-CoA desaturase enzyme, proprotein convertase subtilisin\/kexin type 9, etc. have been identified as a potential novel approach for Parkinson\u2019s disease treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>In the current review, we have discussed the possible molecular role of cholesterol homeostasis in Parkinson\u2019s disease progression. We also identified potential therapeutic targets that need to be evaluated clinically for the development of Parkinson\u2019s treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgaa063","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:13:53Z","timestamp":1609456433000},"page":"862-873","source":"Crossref","is-referenced-by-count":11,"title":["Novel therapeutic approaches for Parkinson\u2019s disease by targeting brain cholesterol homeostasis"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-0688","authenticated-orcid":false,"given":"Tanvi Dayanand","family":"Pingale","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy and Technology Management, SVKM\u2019S NMIMS , Shirpur, Maharashtra ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girdhari Lal","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy and Technology Management, SVKM\u2019S NMIMS , Shirpur, Maharashtra ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"2024103012060893300_CIT0001","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","article-title":"Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson\u2019s disease.","volume":"101","author":"Doria","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2024103012060893300_CIT0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Lecu","year":"2019","journal-title":"Front Neurosci"},{"key":"2024103012060893300_CIT0003","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and Parkinsonism.","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"key":"2024103012060893300_CIT0004","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease.","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2024103012060893300_CIT0005","first-page":"e5409","article-title":"Juvenile Parkinson disease.","volume":"11","author":"Anwar","year":"2019","journal-title":"Cureus"},{"key":"2024103012060893300_CIT0006","first-page":"1545","article-title":"\u201cGlobal, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017\u201d","volume":"388","author":"GBD: Disease Injury Incidence Prevalence Collaborators (October 2017).","year":"2017","journal-title":"Lancet"},{"key":"2024103012060893300_CIT0007","doi-asserted-by":"crossref","first-page":"896912","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"2024103012060893300_CIT0008","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10571-018-0587-4","article-title":"Parkinson disease from mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process","volume":"38","author":"Karimi-Moghadam","year":"2018","journal-title":"Cell Mol Neurobiol"},{"key":"2024103012060893300_CIT0009","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1021\/acs.biochem.6b00342","article-title":"Cholesterol biosynthesis: a mechanistic overview.","volume":"55","author":"Cerqueira","year":"2016","journal-title":"Biochemistry"},{"key":"2024103012060893300_CIT0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol Chem"},{"key":"2024103012060893300_CIT0011","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuint.2015.07.025","article-title":"Cholesterol - a putative endogenous contributor towards Parkinson\u2019s disease","volume":"90","author":"Paul","year":"2015","journal-title":"Neurochem Int"},{"key":"2024103012060893300_CIT0012","first-page":"939","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J Neuro Chem"},{"key":"2024103012060893300_CIT0013","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00041433-199706000-00009","article-title":"Scavenger receptor BI--a cell surface receptor for high-density lipoprotein","volume":"8","author":"Rigotti","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"2024103012060893300_CIT0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1073858414568122","article-title":"24(S) Hydroxycholesterol as a modulator of neuronal signaling and survival","volume":"22","author":"Sun","year":"2016","journal-title":"Neuroscientist"},{"key":"2024103012060893300_CIT0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","article-title":"Role of ATP-binding cassette transporters in brain lipid transport and neurological disease","volume":"104950","author":"Kim","year":"2008","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","article-title":"Cholesterol metabolism in the brain and its association with Parkinson\u2019s disease.","volume":"28","author":"Jin","year":"2019","journal-title":"Exp Neurobiol"},{"key":"2024103012060893300_CIT0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"2024103012060893300_CIT0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"2024103012060893300_CIT0019","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1194\/jlr.R200021-JLR200","article-title":"Lipid rafts: bringing order to chaos","volume":"44","author":"Pike","year":"2003","journal-title":"J Lipid Res"},{"key":"2024103012060893300_CIT0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuropharm.2008.02.019","article-title":"Lipid rafts, cholesterol, and the brain","volume":"55","author":"Korade","year":"2008","journal-title":"Neuropharmacology"},{"key":"2024103012060893300_CIT0021","doi-asserted-by":"crossref","first-page":"25562","DOI":"10.1021\/jp064931u","article-title":"Major factor in sterols\u2019 ordering capability in membranes","volume":"110","author":"Aittoniemi","year":"2006","journal-title":"J Phys Chem B"},{"key":"2024103012060893300_CIT0022","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10312","article-title":"Evidence that the accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis","volume":"52","author":"Cutler","year":"2002","journal-title":"Ann Neurol"},{"key":"2024103012060893300_CIT0023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuroscience.2018.07.041","article-title":"Accumulation of cholesterol and homocysteine in the nigrostriatal pathway of brain contributes to the dopaminergic neurodegeneration in mice.","volume":"388","author":"Paul","year":"2018","journal-title":"Neuroscience"},{"key":"2024103012060893300_CIT0024","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"2024103012060893300_CIT0025","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/mds.27413","article-title":"Higher serum cholesterol and decreased Parkinson\u2019s disease risk: a statin-free cohort study.","volume":"33","author":"Rozani","year":"2018","journal-title":"Mov Disord"},{"key":"2024103012060893300_CIT0026","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol Med"},{"key":"2024103012060893300_CIT0027","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson\u2019s disease: prospective results from Honolulu-Asia Aging Study.","volume":"23","author":"Huang","year":"2008","journal-title":"Mov Disord"},{"key":"2024103012060893300_CIT0028","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwj283","article-title":"Serum cholesterol levels and the risk of Parkinson\u2019s disease.","volume":"164","author":"Lonneke","year":"2006","journal-title":"Am J Epidemiol"},{"key":"2024103012060893300_CIT0029","doi-asserted-by":"crossref","first-page":"III30","DOI":"10.1007\/s00415-003-1306-7","article-title":"Environmental, lifestyle, and physical precursors of clinical Parkinson\u2019s disease: recent findings from the Honolulu-Asia Aging Study.","volume":"250","author":"Abbott","year":"2003","journal-title":"J Neurol"},{"key":"2024103012060893300_CIT0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15252\/embr.201439225","article-title":"Cholesterol in brain disease: sometimes determinant and frequently implicated.","volume":"15","author":"Mart\u00edn","year":"2014","journal-title":"EMBO Rep"},{"key":"2024103012060893300_CIT0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0404.2006.00683.x","article-title":"Cholesterol metabolism in the brain: the importance of 24S-hydroxylation","volume":"185","author":"Lutjohann","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"2024103012060893300_CIT0032","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1194\/jlr.M200434-JLR200","article-title":"Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers","volume":"44","author":"Leoni","year":"2003","journal-title":"J Lipid Res"},{"key":"2024103012060893300_CIT0033","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1471-4159.2008.05736.x","article-title":"Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells","volume":"107","author":"Rantham Prabhakara","year":"2008","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0034","first-page":"pii","author":"Marwarha","year":"2014","journal-title":"Exp Gerontol"},{"key":"2024103012060893300_CIT0035","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/neup.12204","article-title":"Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies","volume":"35","author":"Nakamura","year":"2015","journal-title":"Neuropathology"},{"key":"2024103012060893300_CIT0036","doi-asserted-by":"crossref","first-page":"e0171285","DOI":"10.1371\/journal.pone.0171285","article-title":"Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson\u2019s disease: involvement of mitochondrial dysfunctions and oxidative stress","volume":"12","author":"Paul","year":"2017","journal-title":"PLoS One"},{"key":"2024103012060893300_CIT0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000481551","article-title":"1-methyl-4-phenylpyridinium-induced death of differentiated SH-SY5Y neurons is potentiated by cholesterol","volume":"24","author":"Raju","year":"2018","journal-title":"Ann Neurosci"},{"key":"2024103012060893300_CIT0038","doi-asserted-by":"crossref","first-page":"58","DOI":"10.32607\/20758251-2016-8-1-58-73","article-title":"Brain cholesterol metabolism, and its defects: linkage to neurodegenerative diseases and synaptic dysfunction","volume":"8","author":"Petrov","year":"2016","journal-title":"Acta Naturae"},{"key":"2024103012060893300_CIT0039","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12868-018-0420-5","article-title":"27-Hydroxycholesterol increases \u03b1-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons","volume":"19","author":"Schommer","year":"2018","journal-title":"BMC Neurosci"},{"key":"2024103012060893300_CIT0040","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.bbamem.2011.06.017","article-title":"The fusogenic tilted peptide (67-78) of \u03b1-synuclein is a cholesterol-binding domain","volume":"1808","author":"Fantini","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2024103012060893300_CIT0041","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/molecules22101769","article-title":"\u03b1-synuclein regulates neuronal cholesterol efflux","volume":"22","author":"Hsiao","year":"2017","journal-title":"Molecules"},{"key":"2024103012060893300_CIT0042","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2009.11.015","article-title":"Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies","volume":"221","author":"Koob","year":"2010","journal-title":"Exp Neurol"},{"key":"2024103012060893300_CIT0043","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1471-4159.2006.04348.x","article-title":"Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice","volume":"101","author":"Barcel\u00f3-Coblijn","year":"2007","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0044","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.febslet.2015.08.013","article-title":"Cholesterol facilitates interactions between \u03b1-synuclein oligomers and charge-neutral membranes","volume":"589","author":"Van Maarschalkerweerd","year":"2015","journal-title":"FEBS Lett"},{"key":"2024103012060893300_CIT0045","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI44736","article-title":"Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells","volume":"121","author":"Kim","year":"2011","journal-title":"J Clin Invest"},{"key":"2024103012060893300_CIT0046","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","article-title":"HDL and cholesterol handling in the brain","volume":"103","author":"Vitali","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2024103012060893300_CIT0047","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/00207454.2014.979288","article-title":"The serum lipid profile of Parkinson\u2019s disease patients: a study from China","volume":"125","author":"Guo","year":"2015","journal-title":"Int J Neurosci"},{"key":"2024103012060893300_CIT0048","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1074\/jbc.M108414200","article-title":"Lipid droplet binding and oligomerization properties of the Parkinson\u2019s disease protein alpha-synuclein.","volume":"277","author":"Cole","year":"2002","journal-title":"J Biol Chem"},{"key":"2024103012060893300_CIT0049","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-94-007-3015-1_5","article-title":"Role of phosphoinositides at the neuronal synapse.","volume":"59","author":"Frere","year":"2012","journal-title":"Subcell Biochem"},{"key":"2024103012060893300_CIT0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00401-011-0926-8","article-title":"Aggregation of \u03b1-Synuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons","volume":"123","author":"Taschenberger","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2024103012060893300_CIT0051","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J Biol Chem"},{"key":"2024103012060893300_CIT0052","doi-asserted-by":"crossref","first-page":"41958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long-chain polyunsaturated fatty acids triggers the rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J Biol Chem"},{"key":"2024103012060893300_CIT0053","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1042\/BCJ20170200","article-title":"\u03b1-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking","volume":"474","author":"Lou","year":"2017","journal-title":"Biochem J"},{"key":"2024103012060893300_CIT0054","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jmb.2011.03.009","article-title":"Molecular basis for the glycosphingolipid-binding specificity of \u03b1-synuclein: the key role of tyrosine 39 in membrane insertion","volume":"408","author":"Fantini","year":"2011","journal-title":"J Mol Biol"},{"key":"2024103012060893300_CIT0055","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1074\/jbc.M114.585703","article-title":"Acceleration of alpha-synuclein aggregation by exosomes.","volume":"290","author":"Grey","year":"2015","journal-title":"J Biol Chem"},{"key":"2024103012060893300_CIT0056","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2009.05.008","article-title":"Mutations in the Parkinson\u2019s disease genes, Leucine-Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA) are not associated with essential tremor.","volume":"16","author":"Clark","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"2024103012060893300_CIT0057","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41467-018-03241-9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates alpha-synuclein.","volume":"9","author":"Ryan","year":"2018","journal-title":"Nat Commun"},{"key":"2024103012060893300_CIT0058","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.1021\/bi061743l","article-title":"Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation.","volume":"45","author":"Broersen","year":"2006","journal-title":"Biochemistry"},{"key":"2024103012060893300_CIT0059","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.3390\/ijms160818865","article-title":"Major alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia nigra using an early-stage model of Parkinson\u2019s disease.","volume":"16","author":"Farmer","year":"2015","journal-title":"Int J Mol Sci"},{"key":"2024103012060893300_CIT0060","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1515\/cclm-2013-0358","article-title":"Recent advances in physiological lipoprotein metabolism","volume":"52","author":"Ramasamy","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2024103012060893300_CIT0061","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2016.02.042","article-title":"Effects of different isoforms of apoE on aggregation of the \u03b1-synuclein protein implicated in Parkinson\u2019s disease","volume":"618","author":"Emamzadeh","year":"2016","journal-title":"Neurosci Lett"},{"key":"2024103012060893300_CIT0062","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2006.07.037","article-title":"Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson\u2019s disease","volume":"406","author":"Bl\u00e1zquez","year":"2006","journal-title":"Neurosci Lett"},{"key":"2024103012060893300_CIT0063","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1523\/JNEUROSCI.5471-06.2007","article-title":"Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1","volume":"27","author":"Hayashi","year":"2007","journal-title":"J Neurosci"},{"key":"2024103012060893300_CIT0064","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12031-017-0942-9","article-title":"Role of Apolipoproteins and \u03b1-synuclein in Parkinson\u2019s disease.","volume":"62","author":"Emamzadeh","year":"2017","journal-title":"J Mol Neurosci"},{"key":"2024103012060893300_CIT0065","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov Disord"},{"key":"2024103012060893300_CIT0066","first-page":"350","article-title":"Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease","volume":"122","author":"Wang","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"2024103012060893300_CIT0067","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Ann Neurol"},{"key":"2024103012060893300_CIT0068","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0546-4","article-title":"Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies","volume":"104","author":"Sasaki","year":"2002","journal-title":"Acta Neuropathol"},{"key":"2024103012060893300_CIT0069","first-page":"361","article-title":"Apolipoprotein D expression in substantia nigra of Parkinson disease","volume":"21","author":"Ordo\u00f1ez","year":"2006","journal-title":"Histol Histopathol"},{"key":"2024103012060893300_CIT0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"Clin Lipidol"},{"key":"2024103012060893300_CIT0071","doi-asserted-by":"crossref","first-page":"e77852","DOI":"10.1371\/journal.pone.0077852","article-title":"Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration","volume":"8","author":"Navarro","year":"2013","journal-title":"PLoS One"},{"key":"2024103012060893300_CIT0072","doi-asserted-by":"crossref","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","article-title":"Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding","volume":"285","author":"Hong","year":"2010","journal-title":"J Biol Chem"},{"key":"2024103012060893300_CIT0073","doi-asserted-by":"crossref","first-page":"e1005907","DOI":"10.1371\/journal.pcbi.1005907","article-title":"A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition","volume":"14","author":"Zeppelin","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"2024103012060893300_CIT0074","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1021\/bi700429z","article-title":"Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.","volume":"46","author":"Adkins","year":"2007","journal-title":"Biochemistry"},{"key":"2024103012060893300_CIT0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.12007","article-title":"Importance of cholesterol in dopamine transporter function.","volume":"123","author":"Jones","year":"2012","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0076","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"2024103012060893300_CIT0077","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1083\/jcb.127.5.1217","article-title":"Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules","volume":"127","author":"Schnitzer","year":"1994","journal-title":"J Cell Biol"},{"key":"2024103012060893300_CIT0078","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JPD-171113","article-title":"Statins and cognition in Parkinson\u2019s disease.","volume":"7","author":"Deck","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"2024103012060893300_CIT0079","doi-asserted-by":"crossref","first-page":"e14852","DOI":"10.1097\/MD.0000000000014852","article-title":"Effect of statins on Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"key":"2024103012060893300_CIT0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JPD-171203","article-title":"Simvastatin as a potential disease-modifying therapy for patients with Parkinson\u2019s disease: rationale for clinical trial, and current progress.","volume":"7","author":"Carroll","year":"2017","journal-title":"J Parkinson\u2019s Dis"},{"key":"2024103012060893300_CIT0081","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1172\/JCI119812","article-title":"Lovastatin, and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages","volume":"100","author":"Pahan","year":"1997","journal-title":"J Clin Invest"},{"key":"2024103012060893300_CIT0082","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1073858410385006","article-title":"Prospects of statins in Parkinson disease","volume":"17","author":"Roy","year":"2011","journal-title":"Neuroscientist"},{"key":"2024103012060893300_CIT0083","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate Parkinson\u2019s disease: insight gained from a large, national claims database.","volume":"32","author":"Liu","year":"2017","journal-title":"Mov Disord"},{"key":"2024103012060893300_CIT0084"},{"key":"2024103012060893300_CIT0085","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat Genet"},{"key":"2024103012060893300_CIT0086","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","article-title":"Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis","volume":"136","author":"Harlalka","year":"2013","journal-title":"Brain"},{"key":"2024103012060893300_CIT0087","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with Parkinson\u2019s disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J Neurosci Res"},{"key":"2024103012060893300_CIT0088","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1471-4159.1998.70041335.x","article-title":"GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems","volume":"70","author":"Hadjiconstantinou","year":"1998","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0089","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jnc.14146","article-title":"Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells","volume":"143","author":"Chiricozzi","year":"2017","journal-title":"J Neurochem"},{"key":"2024103012060893300_CIT0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-9255-5-17","article-title":"Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines\u2019 unexpected therapeutic properties.","volume":"5","author":"Cunningham","year":"2008","journal-title":"J Inflamm"},{"key":"2024103012060893300_CIT0091","first-page":"379","article-title":"Inhibition of brain phospholipase A2 by antimalarial drugs: implications for neuroprotection in neurological disorders","volume":"2","author":"Farooqui","year":"2005","journal-title":"Med Chem Rev"},{"key":"2024103012060893300_CIT0092","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1568006043481239","article-title":"Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration.","volume":"4","author":"Farooqui","year":"2004","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"2024103012060893300_CIT0093","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson\u2019s disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci Lett"},{"key":"2024103012060893300_CIT0094","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci Lett"},{"key":"2024103012060893300_CIT0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","article-title":"Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases","volume":"29","author":"Dalfo","year":"2008","journal-title":"Neurobiol Aging"},{"key":"2024103012060893300_CIT0096","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/biom5010178","article-title":"\u03b1-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.","volume":"5","author":"Bate","year":"2015","journal-title":"Biomolecules"},{"key":"2024103012060893300_CIT0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10052-008-0002-2","article-title":"Cytosolic phospholipase A 2 and its role in Parkinson\u2019s disease","volume":"1","author":"Stolecka","year":"2010","journal-title":"Adv Cell Biol"},{"key":"2024103012060893300_CIT0098","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0361-9230(00)00427-5","article-title":"Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.","volume":"54","author":"Tariq","year":"2001","journal-title":"Brain Res Bull"},{"key":"2024103012060893300_CIT0099","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of a-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol Cell"},{"key":"2024103012060893300_CIT0100","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","article-title":"Inhibiting Stearoyl-CoA desaturase ameliorates \u03b1-synuclein cytotoxicity.","volume":"25","author":"Vincent","year":"2018","journal-title":"Cell Rep"},{"key":"2024103012060893300_CIT0101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1194\/jlr.R075507","article-title":"The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease","volume":"58","author":"Lane-Donovan","year":"2017","journal-title":"J Lipid Res"},{"key":"2024103012060893300_CIT0102","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1146\/annurev.neuro.24.1.1005","article-title":"Role of the reelin signaling pathway in central nervous system development.","volume":"24","author":"Rice","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"2024103012060893300_CIT0103","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9, and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomization study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/73\/7\/862\/60217255\/rgaa063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/73\/7\/862\/60217255\/rgaa063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:48:47Z","timestamp":1730292527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/73\/7\/862\/6209764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":103,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaa063","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,7,1]]}}}